Home › Companies › Definium Therapeutics, Inc. › 2025-2026
At Definium Therapeutics, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 65 asset managers reported how they voted on 9 ballot items in their SEC Form N-PX filings, covering 1,642 separate fund positions. On the most widely held item on that ballot — To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company… — Definium Therapeutics, Inc.'s filing reports the proposal as approved, with 99.8% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Definium Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Definium Therapeutics, Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 11, 2026: 9 items on Definium Therapeutics, Inc.’s Form 8-K, filed June 12, 2026: 2 approved · 7 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Definium Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Definium Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Robert Barrow | 62,881,122 | -- | -- | 173,376 | 15,619,094 | 99.7% | Not verified | — |
| Elect Director: Dr. Suzanne Bruhn | 62,503,873 | -- | -- | 550,625 | 15,619,094 | 99.1% | Not verified | — |
| Elect Director: Dr. Roger Crystal | 60,056,178 | -- | -- | 2,998,320 | 15,619,094 | 95% | Not verified | — |
| Elect Director: David Gryska | 62,760,423 | -- | -- | 294,075 | 15,619,094 | 99.5% | Not verified | — |
| Elect Director: Andreas Krebs | 62,395,043 | -- | -- | 659,455 | 15,619,094 | 99% | Not verified | — |
| Elect Director: Carol A. Vallone | 62,623,945 | -- | -- | 430,553 | 15,619,094 | 99.3% | Not verified | — |
| Elect Director: Roger Adsett | 62,931,294 | -- | -- | 123,204 | 15,619,094 | 99.8% | Not verified | — |
| 2. Appointment of Auditor | 78,579,054 | -- | -- | 94,538 | -- | 99.8% | Approved | — |
| 3. Approval of the Equity Plan Amendment | 58,149,028 | 4,708,102 | 197,368 | -- | 15,619,094 | 93% | Approved | — |
Source: Definium Therapeutics, Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
Each item below shows how the 65 asset managers that disclosed a Definium Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Andreas Krebs”): 62,395,043 for, 659,455 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,233,449 for, 17,504 withheld, 2 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,905,564 | 0 | 2 | 8,946 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Carol A. Vallone”): 62,623,945 for, 430,553 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,229,514 for, 21,440 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,901,234 | 0 | 1 | 13,277 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: David Gryska
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: David Gryska”): 62,760,423 for, 294,075 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,246,624 for, 4,331 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,910,181 | 0 | 1 | 4,331 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert Barrow
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Robert Barrow”): 62,881,122 for, 173,376 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,241,487 for, 9,468 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,905,566 | 0 | 0 | 8,946 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Adsett
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Roger Adsett”): 62,931,294 for, 123,204 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,250,955 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,914,512 | 0 | 0 | 0 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D.
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Dr. Roger Crystal”): 60,056,178 for, 2,998,320 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,233,441 for, 17,504 withheld, 10 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,905,556 | 0 | 10 | 8,946 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D.
Definium Therapeutics, Inc.’s own tally for this item (“Elect Director: Dr. Suzanne Bruhn”): 62,503,873 for, 550,625 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 18,233,450 for, 17,504 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,905,565 | 0 | 1 | 8,946 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. All 62 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Approved · of votes cast
Description as filed by funds: To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares.
Definium Therapeutics, Inc.’s own tally for this item (“3. Approval of the Equity Plan Amendment”): 58,149,028 for, 4,708,102 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Approval of the Equity Plan Amendment The shareholders approved the Equity Plan Amendment by the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Definium Therapeutics, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “To consider, and if deemed advisable, approve the amendment to the Definium Thrapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares.” (14 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,183,537 | 1,790,735 | 0 | 0 | Mixed |
| Vanguard | 2,905,549 | 8,962 | 0 | 0 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
| Global X | 46,259 | 0 | 0 | 0 | For |
| Northern Trust | 44,845 | 0 | 0 | 0 | For |
| State Street | 44,728 | 0 | 0 | 0 | For |
| Prudential/PGIM | 42,818 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 11,442,048 for, 1,807,338 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Integral Health Asset Management, LLC | 154,821 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 154,821 for.
Combines 2 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders.
Definium Therapeutics, Inc.’s own tally for this item (“2. Appointment of Auditor”): 78,579,054 for, 94,538 withheld — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Appointment of Auditor The shareholders approved the appointment of KPMG LLP as the independent registered public accounting firm (auditor) of the Company until the 2027 Annual Meeting by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 18,250,974 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,523,367 | 0 | 0 | 0 | For |
| Fidelity | 3,974,272 | 0 | 0 | 0 | For |
| Vanguard | 2,914,512 | 0 | 0 | 0 | For |
| TIAA | 1,008,498 | 0 | 0 | 0 | For |
| Charles Schwab | 809,668 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 775,637 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 686,162 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 653,072 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 358,542 | 0 | 0 | 0 | For |
| Royce | 234,000 | 0 | 0 | 0 | For |
| BNY Mellon | 231,178 | 0 | 0 | 0 | For |
| Equitable | 220,656 | 0 | 0 | 0 | For |
| Goldman Sachs | 193,632 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,991 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 150,124 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 136,454 | 0 | 0 | 0 | For |
| JPMorgan | 115,190 | 0 | 0 | 0 | For |
| Jackson National | 111,002 | 0 | 0 | 0 | For |
| Neuberger Berman | 108,529 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 91,301 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,190 | 0 | 0 | 0 | For |
| Russell Investments | 60,256 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 55,414 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 54,273 | 0 | 0 | 0 | For |
| Brighthouse | 53,706 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 109,066,783 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.15% |
| 2 | Fidelity | 3.64% |
| 3 | Vanguard | 2.67% |
| 4 | TIAA | 0.92% |
| 5 | Charles Schwab | 0.74% |
| 6 | DRIEHAUS MUTUAL FUNDS | 0.71% |
| 7 | MUTUAL FUND SERIES TRUST | 0.63% |
| 8 | Columbia Threadneedle | 0.60% |
| 9 | MERIDIAN FUND INC | 0.33% |
| 10 | Royce | 0.21% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Crewe Advisors LLC | <0.01% |
| 2 | Berkeley Capital Partners, LLC | <0.01% |
| 3 | HARBOUR INVESTMENT MANAGEMENT LLC | <0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 8.06% | 13G |
| BlackRock | 7.78% | 13F |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6.28% | 13G |
| Avoro Capital Advisors LLC | 4.58% | 13G |
| Deep Track Capital, LP | 2.75% | 13G |
| Geode Capital | 2.29% | 13F |
| State Street | 2.27% | 13F |
| Commodore Capital LP | 2.21% | 13G |
| FMR (Fidelity) | 1.66% | 13F |
| Goldman Sachs | 1.54% | 13F |
Percentages above are of 109,066,783 shares outstanding, as reported by Definium Therapeutics, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Definium Therapeutics, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Definium Therapeutics, Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Definium Therapeutics (DFTX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/definium-therapeutics-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.